<DOC>
	<DOC>NCT00409708</DOC>
	<brief_summary>This study will assess the frequency of chromosomal abnormalities measured in circulating lymphocytes in treatment-naive children with Attention Deficit Hyperactivity Disorder (ADHD) treated for 3 months with either extended release methylphenidate or behavioral therapy.</brief_summary>
	<brief_title>Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)</brief_title>
	<detailed_description>This study will determine whether the administration of extended-release methylphenidate in treatment-na√Øve children with Attention Deficit Hyperactivity Disorder (ADHD) affects the frequency of chromosomal abnormalities.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Chromosome Aberrations</mesh_term>
	<mesh_term>Chromosome Disorders</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Children of both genders, 612 years old Written informed consent by the parent and the patient (over 7) Diagnosis of ADHD Ageappropriate cognitive functioning All patients who had at least one postbaseline cytogenetic assessment in the core study can enter the observation phase. History of malignant neoplasm History of seizures (except childhood febrile seizures) Hyperthyroidism Concurrent medical condition which may interfere with study Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Attention Deficit Hyperactivity Disorder,</keyword>
	<keyword>ADHD</keyword>
	<keyword>Cytogenetic abnormalities,</keyword>
	<keyword>extended-release methylphenidate,</keyword>
</DOC>